Intellectual property in the health tech and medtech industries is a complex issue, particularly when it comes to collecting and using data from connected medical devices in artificial intelligence algorithms. Data ownership and privacy concerns are key legal questions, with HIPAA playing a significant role. The value of data derived from medical devices for AI models and as a tool in product development is a crucial aspect of IP for healthcare companies. The legal and regulatory challenges for class 1-3 medical devices and diagnostic development are varied, with Class 3 devices facing more hurdles in terms of FDA approval. Predictions for the future include increased use of AI in medical industry, particularly in self-diagnosis, and enhanced AI models trained with connected device data. FDA standards and regulation in the realm of data validation and AI algorithm patentability are still evolving.
Source link
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
